Evoke Wealth, LLC Eli Lilly & CO Transaction History

Evoke Wealth, LLC

$3.36 Billion
Q1 2024

A detailed history of Evoke Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Evoke Wealth, LLC holds 7,172 shares of LLY stock, worth $6.49 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,172

Previous 13,999 48.77%

Holding current value

$6.49 Million

Previous $8.16 Million 31.63%

% of portfolio

0.17%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $4.04 Million - $5.41 Million	-6,827 Reduced 48.77%	7,172 $5.58 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $6.02 Million - $7.1 Million	11,463 Added 452.01%	13,999 $8.16 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $157,796 - $217,545	363 Added 16.71%	2,536 $1.36 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $177,825 - $237,772	507 Added 30.43%	2,173 $1.02 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $77,968 - $91,569	251 Added 17.74%	1,666 $572,000

Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $21,543 - $25,102	-67 Reduced 4.52%	1,415 $517,000
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $1,778 - $2,027	-6 Reduced 0.4%	1,482 $479,000
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $42,924 - $50,399	-154 Reduced 9.38%	1,488 $482,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $33,560 - $41,707	143 Added 9.54%	1,642 $470,000
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $7,195 - $8,929	32 Added 2.18%	1,499 $414,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $33,904 - $41,724	-153 Reduced 9.44%	1,467 $339,000
Q2 2021 Aug 05, 2021	BUY	$180.55 - $233.54 $13,902 - $17,982	77 Added 4.99%	1,620 $372,000
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $80,188 - $103,807	488 Added 46.26%	1,543 $288,000
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $1,043 - $1,381	8 Added 0.76%	1,055 $178,000
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $1,754 - $2,029	-12 Reduced 1.13%	1,047 $155,000
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $34,923 - $42,030	-256 Reduced 19.47%	1,059 $174,000
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $93,930 - $116,259	-789 Reduced 37.5%	1,315 $182 Million
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $35,176 - $43,569	329 Added 18.54%	2,104 $277 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $189,552 - $206,184	1,775 New	1,775 $199 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.

Account